Vol 65, No 2 (2015)
Oncological debates
Published online: 2015-05-06
The content of this article is also available in the following languages:
Polski
Polski
We should not change the current treatment in HER2-positive breast cancer patients with brain metastases developed during trastuzumab administration
DOI: 10.5603/NJO.2015.0029
Nowotwory. Journal of Oncology 2015;65(2):148-150.
Abstract
Not available